Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05645146 · ClinicalTrials.gov registry record · NA

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

A NA study of Smoking Cessation and Cervical Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Active
Registry status
NA
Development phase
360
Enrollment target
1
Study location

NCT05645146: Active NA study of Smoking Cessation and Cervical Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT05645146 is a NA study of Smoking Cessation and Cervical Cancer that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 360 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05645146, a NA study of Smoking Cessation and Cervical Cancer, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to compare the efficacy of a treatment approach that comprises both Motivation And Problem-Solving (MAPS)-based telephone counseling and a personally-tailored SMS-delivered text-based approach to quitline-delivered smoking cessation treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.

Primary Outcome

The primary outcome of this study is self-reported, 7 day point prevalence abstinence over time through the 24 month assessment where participants who report no smoking in the previous 7 days at follow-up assessment are considered abstinent. Efficacy of MAPS vs Standard Treatment will be measured by comparing the number of participants in each group who were able to quit smoking and maintain smoking abstinence for 2 years.

Interventions

  • DRUG Nicotine patch
  • BEHAVIORAL Smoking Cessation treatment delivered by Tobacco Free Florida Quitline
  • DRUG Nicotine Lozenge
  • BEHAVIORAL Motivation and Problem Solving (MAPS) intervention

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2022-11-29
Est. Completion 2028-01
Phase NA

What the registry record for NCT05645146 still lists

NCT05645146 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (24% lower).

The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Nicotine patch is the first listed.

NCT05645146 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05645146 about?

NCT05645146 is a clinical study titled "Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)". The goal of this research study is to compare the efficacy of a treatment approach that comprises both Motivation And Problem-Solving (MAPS)-based telephone counseling and a personally-tailored SMS-delivered text-based approach to quitline-delivered smoking cessation treatment to help participants w...

What is the current status of trial NCT05645146?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2022-11-29. Estimated completion is 2028-01.

What conditions does trial NCT05645146 study?

This clinical trial studies the following conditions: Smoking Cessation, Cervical Cancer, High Grade Cervical Dysplasia.

What interventions are being tested in trial NCT05645146?

The interventions under investigation include: Nicotine patch (DRUG), Smoking Cessation treatment delivered by Tobacco Free Florida Quitline (BEHAVIORAL), Nicotine Lozenge (DRUG), Motivation and Problem Solving (MAPS) intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05645146?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05645146 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05645146's enrollment target sits among peer trials

360 72nd of 188 higher than 117 of 188 other Smoking Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02747836 · 360 participants

    Ultrasound Analysis of Human Carpal Tunnel System

  • NCT04089046 · 360 participants · NA

    Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)

  • NCT04130503 · 360 participants · NA

    The Recovery in Stroke Using PAP Study

  • NCT04160000 · 360 participants · Phase 4

    Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05645146, the US trial registry maintained by the National Library of Medicine. NCT05645146 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.